FDA Inspection 1030369 — Dr. Albert Maguire. Clinical Inv.
The FDA completed an inspection of Dr. Albert Maguire. Clinical Inv. on Oct 20, 2017 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 20, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional details
Clinical Investigator (CI)